Search

The following table contains an overview of first published case reports of adverse drug reactions (ADRs) identified in the international literature in recent weeks by the drug safety alerting service Reactions Weekly. Summarising information selected from over 1700 biomedical publications, Reactions Weekly is produced by Adis International Limited and is available in a variety of formats. Please contact your nearest Adis office for subscription details. [ABSTRACT FROM AUTHOR]

Presents a table that contains an overview of first published case reports of adverse drug reactions identified in the international literature in recent weeks. Antithymocyte globulin/cyclosporin; Apomorphine; Buprenorphine/morphine.

A table is presented that offers an overview on case reports of serious adverse drug reactions named by the drug safety alerting service "Reactions Weekly."

A published report of one or more adverse events can provide a useful signal of possible risks associated with the use of a drug or medical product. However, shortcomings in vital information in published cases can often limit the value of such reports by failing to provide sufficient details. Recent guidelines endorsed by the International Society for Pharmacoepidemiology and the International Society of Pharmacovigilance have identified information that should always be considered for inclusion in a report submitted for publication [ABSTRACT FROM AUTHOR]

The following table contains an overview of first published case reports of adverse drug reactions (ADRs) identified in the international literature in recent weeks by the drug safety alerting service Reactions Weekly. Summarising information selected from over 1700 biomedical publications, this newsletter is produced by Adis International Limited and is available in a variety of formats. Please contact your nearest Adis office for subscription details. [ABSTRACT FROM AUTHOR]

The following table contains an overview of first published case reports of adverse drug reactions identified in the international literature in recent weeks by the drug safety alerting service Reactions Weekly. Summarising information selected from over 1700 biomedical publications, this newsletter is produced by Adis International Limited and is available in a variety of formats. Please contact your nearest Adis office for subscription details. [ABSTRACT FROM AUTHOR]

Presents a table that contains an overview of first published case reports of adverse drug reactions identified in the international literature in recent weeks by the drug safety alerting service "Reactions Weekly." Amlodipine overdose; Anagrelide overdose; Anagrelide overdose.

A table is presented depicting an overview of first published case reports of serious adverse drug reactions (ADRs) identified by the drug safety alerting service Reactions Weekly in the international literature.

A table is presented that lists the first published international case reports of adverse drug reactions (ADRs) as identified by the drug safety alert service, Reactions Weekly, including Antiepileptics: anger (ehosuximide) or nightmares (pregabalin) and Antineoplastics: acute lymphoblastic leukaemia (bleomycin/cytarabine) or fatal acute myelomonocytic leukaemia (cytarabine).

A chart is presented that shows the first reports of serious adverse drug reactions.

A table is presented that contains an overview of first published case reports of serious adverse drug reactions (ADRs) identified in the international literature as of July 2001 by the drug safety alerting service "Reactions Weekly."

The under-reporting of adverse drug reactions (ADRs) has an effect on the risk evaluation of drugs, particularly if spontaneous reports are the main source used in assessing drug safety. A systematic review conducted to investigate the level of under-reporting of ADRs to spontaneous reporting systems provides evidence of significant and widespread under-reporting [ABSTRACT FROM AUTHOR]

During pregnancy, allergic rhinitis is a frequent problem and physiological changes associated with pregnancy can also affect the upper airways. Medication can be prescribed during pregnancy when the apparent benefits of treatment outweigh its apparent risks [ABSTRACT FROM AUTHOR]

Presents a table containing an overview of first published case reports of adverse drug reactions identified in the international literature from July 2003 to March 2004 by "Reactions Weekly."

Presents a chart of published case reports of adverse drug reactions identified in the international literature as of February 2003, including migraine from isoflavones published in the October 22, 2002 issue of "Neurology."

The article presents an overview for the case report of the serious adverse drug reactions (ADR) identified by the "Reactions Weekly." It states that the drug safety alerting service has listed the serious ADR cases based on the disability, hospitalization, life-threatening and death of the patient. The drugs and ADR includes abacavir for Still's disease, dasatinib for pulmonary arterial hypertension and ketamine for acute stress cardiomyopathy.

A chart is presented that contains an overview of first published case reports of serious adverse drug reactions (ADR) identified in the international literature in recent weeks by the drug safety alerting service "Reactions Weekly."

A table is presented that lists published case reports of drug reactions and interactions as of October 2007 which include Bevacizumab, Cetuximab and Solifenacin.

A table is presented that contains an overview of first published case reports of serious adverse drug reactions (ADR) identified by the drug safety alerting service "Reactions Weekly."

A table is presented that contains an overview of first published case reports of serious adverse drug reactions (ADRs) identified in the international literature by the drug safety alerting service "Reactions Weekly."

A table is presented that contains an overview of first published case reports of serious adverse drug reactions identified in the international literature by the drug safety alerting service Reactions Weekly as of April 2007.

Women appear to be at higher risk for selected antiretroviral-associated adverse events than men. Although the aetiology for a gender difference in antiretroviral tolerance among non-pregnant adults is unknown, possible contributing factors include gender-specific physiological and hormonal influences or unique pharmacokinetic profiles. The risk of selected toxicities may be influenced by pregnancy [ABSTRACT FROM AUTHOR]

Clear and consistent terminology for drug safety issues helps prevent ambiguity, and allows patients, healthcare professionals, manufacturers and regulators to understand each other. However, existing terms describing medicines, formulations and adverse drug effects are often inadequate, and more suitable definitions have been suggested. The terminology used in the classification of the frequency, intensity and seriousness of adverse effects is also discussed and definitions modified [ABSTRACT FROM AUTHOR]

The following table contains an overview of first published case reports of adverse drug reactions identified in the international literature in recent weeks by the drug safety alerting service Reactions Weekly. Summarising information selected from over 1700 biomedical publications, this newsletter is produced by Adis International Limited and is available in a variety of formats. Please contact your nearest Adis office for subscription details. [ABSTRACT FROM AUTHOR]